Project Grant HT94252510887
Award Date 9/15/25
Completion Date 9/14/29
Dollars Obligated $1.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
- Sloan-Kettering Institute For Cancer Research was awarded a $796,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of July 15, 2023 through July 14, 2026. The grant will support research to develop novel tools to improve responses to DNA-damaging therapeutics in metastatic breast cancer. As the prime recipient, Sloan-Kettering Institute For Cancer Research will leverage its expertise in cancer biology,...
- The Sloan-Kettering Institute for Cancer Research was awarded a $707,346 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2024, supports Sloan-Kettering's cancer research initiatives, including investigations into the tumor microenvironment, mechanisms of metastasis, epigenetic alterations in cancer, resistance to cancer therapies, aging-related biology, and hematologic malignancies....
- Sloan-Kettering Institute For Cancer Research was awarded a $845,789 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2023 to June 30, 2026. The grant will support research to discover biomarkers and address outcome disparities for prostate cancer through exploiting real-world clinical genomic data. As the prime recipient, Sloan-Kettering Institute For Cancer Research will leverage its expertise...
- The Defense Health Agency awarded a $619,500 Project Grant to the Sloan-Kettering Institute for Cancer Research, a non-profit organization in New York, NY. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program and will support research to investigate the immunogenicity and targeting of shared neoantigens in adenoid cystic cancer over a 3-year period from September 1, 2023 to August 31, 2026. The research aims to transform health care for Service...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $923,805.00 to the Sloan-Kettering Institute for Cancer Research in New York to conduct research on "Systematic Functional Dissection of Cancer Cell States in Lung Tumors." The award period runs from Sep 1, 2025 through Aug 31, 2028. The research aims to transform healthcare for military service members, veterans, and the general public by...
- The Defense Health Agency awarded a $924,000 Project Grant to the Sloan-Kettering Institute for Cancer Research in New York, NY under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2025, supports research to develop "Therapeutic Strategies for Targeting Diverse KRAS Mutations in Lung Cancer" with a performance period through May 31, 2028. The Sloan-Kettering Institute, a leading comprehensive cancer center, will conduct advanced...
- The Sloan-Kettering Institute for Cancer Research was awarded a $906,740 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop an application for following images of nevi (moles) to detect melanoma. The project will be conducted over a 3-year period from August 1, 2023 to July 31, 2026. Through this federal grant, the Sloan-Kettering Institute, a non-profit research organization, will focus on innovative and impactful...
- The Sloan-Kettering Institute for Cancer Research was awarded a $1,295,691 Project Grant on November 1, 2024 under the Military Medical Research and Development (CFDA 12.420) federal grant program, administered by the Defense Health Agency. The funding will support research aimed at "Targeting Hypermethylation to Overcome Cisplatin Resistance in Patients with Relapsed/Refractory Germ Cell Tumors" over a performance period ending on October 31, 2027. As a leading comprehensive cancer...
- The Sloan-Kettering Institute for Cancer Research was awarded a $923,999 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on understanding the effects of tobacco smoking on African American patients with lung cancer. The award will support a multi-year research initiative from July 1, 2024 to June 30, 2027. As a non-profit organization focused on cancer research and patient care, Sloan-Kettering Institute for...
- This $176,000 Project Grant awarded by the Department of Defense (DOD) through the Military Medical Research and Development program (CFDA 12.420) supports research by the Sloan-Kettering Institute for Cancer Research to define the biology of and identify therapeutic vulnerabilities in DCK12-inactivated prostate cancer. The award period is from April 1, 2024 to March 31, 2025. As a non-profit organization focused on cancer research and patient care, Sloan-Kettering Institute has previously...